18931014

Source:http://linkedlifedata.com/resource/pubmed/id/18931014

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003241, umls-concept:C0027651, umls-concept:C0038952, umls-concept:C0039082, umls-concept:C0205494, umls-concept:C0235031, umls-concept:C0332307, umls-concept:C1427047, umls-concept:C1441055, umls-concept:C1826624
pubmed:issue	4
pubmed:dateCreated	2009-3-17
pubmed:abstractText	Anti-Hu antibodies (Hu-Ab) and anti-CV2/CRMP5 antibodies (CV2/CRMP5-Ab) have been identified in association with paraneoplastic neurological disorders. However, it is not clear whether these antibodies are associated with specific neurological symptoms or are only markers of anti-cancer immune reaction.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-11064826, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-11220734, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-11220741, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-11353730, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-11549731, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-11706981, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-11725180, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-11834602, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-12112110, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-12838519, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-1312683, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-14673901, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-15258215, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-15468074, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-16519949, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-18861108, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-1944905, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-8410058, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-8795598, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-9521251, http://linkedlifedata.com/resource/pubmed/commentcorrection/18931014-9600223
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985191R
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/DPYSL5 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Hu Paraneoplastic..., http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1468-330X
pubmed:author	pubmed-author:AgueraMM, pubmed-author:AntoineJ CJC, pubmed-author:CamdessancheJ PhJP, pubmed-author:CarpentierA FAF, pubmed-author:Cartalat-CarelSS, pubmed-author:ChapuisFF, pubmed-author:DecullierEE, pubmed-author:DucheminA MAM, pubmed-author:GrausFF, pubmed-author:HonnoratJJ, pubmed-author:RicardDD, pubmed-author:RogemondVV
pubmed:issnType	Electronic
pubmed:volume	80
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	412-6
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:18931014-Adult, pubmed-meshheading:18931014-Age of Onset, pubmed-meshheading:18931014-Aged, pubmed-meshheading:18931014-Antibodies, Neoplasm, pubmed-meshheading:18931014-Brain Neoplasms, pubmed-meshheading:18931014-Female, pubmed-meshheading:18931014-Hu Paraneoplastic Encephalomyelitis Antigens, pubmed-meshheading:18931014-Humans, pubmed-meshheading:18931014-Male, pubmed-meshheading:18931014-Middle Aged, pubmed-meshheading:18931014-Nerve Tissue Proteins, pubmed-meshheading:18931014-Nervous System Diseases, pubmed-meshheading:18931014-Paraneoplastic Syndromes, Nervous System, pubmed-meshheading:18931014-Prognosis, pubmed-meshheading:18931014-Survival Analysis, pubmed-meshheading:18931014-Thymoma
pubmed:year	2009
pubmed:articleTitle	Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
pubmed:affiliation	Centre de Référence Maladies Rares Syndromes Neurologiques Paranéoplasiques, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France. jerome.honnorat@chu-lyon.fr
pubmed:publicationType	Journal Article